Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.05
-0.0260-1.25%
Post-market: 2.120.0659+3.21%19:37 EDT
Volume:96.59K
Turnover:199.80K
Market Cap:34.74M
PE:-0.87
High:2.10
Open:2.09
Low:2.03
Close:2.08
Loading ...

NRx Pharmaceuticals Unit Signs Letter of Intent to Acquire Neurospa TMS

MT Newswires Live
·
24 Mar

BRIEF-HOPE Therapeutics and NRx Pharmaceuticals Sign Binding Letter of Intent with Neurospa TMS Holdings

Reuters
·
24 Mar

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Signing of Binding Letter of Intent With Neurospa Tms Holdings, Llc for Expansion of Its Planned International Network of Interventional Psychiatry Clinics

THOMSON REUTERS
·
24 Mar

Hope Therapeutics : Acquisition to Be Accretive to Hope Revenue Projections for 2025

THOMSON REUTERS
·
24 Mar

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics

Dow Jones
·
24 Mar

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Mar

NRX Pharmaceuticals Inc (NRXP) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial ...

GuruFocus.com
·
18 Mar

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
17 Mar

NRX Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
17 Mar

NRX Pharmaceuticals Inc - Forecasts Profitability by Year End 2025

THOMSON REUTERS
·
17 Mar

Press Release: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
17 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

NRx Pharmaceuticals, Inc. (NRXP): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
01 Mar

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025

PR Newswire
·
06 Feb

NRx Pharmaceuticals, Hope Therapeutics engage BTIG as financial advisor

TIPRANKS
·
03 Feb

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor

PR Newswire
·
03 Feb